Group 1 - The growth algorithm from CoreWeave is unprecedented, indicating strong demand and significant growth rates that are described as insatiable and relentless [1] - There is a substantial backlog of demand that suggests this growth trend will continue without slowing down in the near future [1] Group 2 - The demand for CoreWeave's services is foundational and is expected to be durable not just through 2026 but also into 2030 [2] - The company is actively discussing targets that extend beyond the immediate future, indicating confidence in sustained demand [2]

CAGNY 2026 A PROVEN GROWTH MODEL, POSITIONED TO REACCELERATE GROWTH February 17, 2026 FORWARD-LOOKING STATEMENTS This presentation and accompanying prepared remarks contain forward-looking statements. All statements other than statements of historical fact are "forward-looking statements" for purposes of federal and state securities laws. Words, and variations of words, such as "will," "may," "expect," "would," "could," "might," "intend," "plan," "believe," "likely," "estimate," "anticipate," "objective," " ...

Summary of Guardian Pharmacy Services Conference Call Company Overview - **Company**: Guardian Pharmacy Services (NYSE: GRDN) - **Industry**: Institutional pharmacy services focused on long-term care, specifically assisted living facilities [2][3] Core Insights and Arguments - **Market Position**: Guardian holds a 13% market share in the assisted living pharmacy segment, indicating significant growth potential with 87% of the market still available [3] - **Target Demographic**: The company serves a highly acute population in assisted living, with residents averaging 85 years of age and 14 prescriptions each [2] - **Growth Strategy**: Guardian aims for low double-digit growth, supported by a combination of organic growth and acquisitions. Historical revenue growth has been around 15% since inception [8][9] - **Industry Dynamics**: The assisted living sector is transitioning from a real estate focus to a healthcare focus, with increasing consolidation and demand for sophisticated services [9][10] - **Pricing and Reimbursement**: The company is working to improve reimbursement rates by negotiating directly with payors, moving away from third-party networks [10][11] Challenges and Legislative Impact - **Inflation Reduction Act (IRA)**: The IRA poses a potential headwind, expected to impact revenue by over $100 million in 2026 and create a $5 million EBITDA headwind [11][12] - **Mitigation Strategies**: Guardian is actively engaging in legislative efforts and commercial negotiations to mitigate the impact of the IRA [12][14] M&A and Market Expansion - **Acquisition Strategy**: The company seeks to acquire pharmacies with strong operators who can benefit from Guardian's support and scale. The focus is on collaborative operators rather than complete buyouts [17][18] - **Market Entry**: Recent expansions into Oregon and Washington are seen as case studies for successful market entry, leveraging existing strong operators [19][20] Adjacent Market Opportunities - **PACE Programs and Hospice Pharmacy**: Guardian is exploring adjacent markets such as PACE programs and hospice pharmacy services, which present significant growth opportunities [23][25] Investor Insights - **Underappreciated Aspects**: Investors may not fully recognize the virtuous cycle of scale that enhances profitability and market share. Guardian's focus on a different segment of the long-term care market distinguishes it from legacy players [26][27] Financial Health - **Cash Flow and Capital Deployment**: The company has a strong cash conversion ratio of approximately 60%, providing flexibility for M&A and other capital deployment strategies [21][22] This summary encapsulates the key points discussed during the Guardian Pharmacy Services conference call, highlighting the company's market position, growth strategies, challenges, and opportunities within the industry.